The NHLBI is offering the Catalyze Product Definition Grant to advance therapeutic candidates for HLBS diseases.
SynopsisVersion HistoryRelated DocumentsPackage The National Heart, Lung, and Blood Institute (NHLBI) is offering this Catalyze Product Definition grant to facilitate the early-stage translation of basic science discoveries into viable diagnostic and therapeutic candidates. This grant is for supporting the identification and characterization of potential therapeutic candidates, including small molecules, biologics, and combination products, to address Heart, Lung, Blood, and Sleep (HLBS) diseases and disorders. The program also aims to develop translational [...]